临床所见腹膜假粘液瘤(PP)常在腹膜和大网膜种植,含有大量胶冻样粘液或胶冻样腹水,来源于良性或恶性病变,可并发功能紊乱和梗阻导致死亡,死亡率至少50%,目前尚无有效治疗。OK-432是一种稀释的溶血性链球菌制剂,用于治疗恶性疾病,是一种非特异性免疫治疗。本研究的目的在于弄清PP在首次手术后给0K-432作为辅助治疗是否有效。 Peritoneal pseudomyxoma (PP) is often seen in the peritoneum and omentum planted with a large number of jelly-like mucus or jelly-like ascites, derived from benign or malignant lesions, may be complicated by dysfunction and obstruction leading to death, the mortality rate of at least 50%, there is no effective treatment. OK-432 is a diluted hemolytic streptococcal preparation for the treatment of malignant diseases and is a nonspecific immunotherapy. The purpose of this study was to determine if PP was effective as adjuvant therapy for 0K-432 after the first surgery.